Pathology & Laboratory Medicine

You are here

News

The Molecular Pathology Laboratory launches new Cancer Gene Mutation Panel (50 Gene Panel)

The Cancer Gene Mutation Panel- 50 (CGMP-50) test is a Targeted Next Generation Sequencing (NGS) assay that is used to interrogate the variant status of 50 cancer-related genes in solid tumors including but not limited to Colorectal, Lung, Brain, Ovarian, Thyroid, Breast cancers and Melanomas. The assay is performed on the Ion Torrent Personal Genome Machine (PGM) platform.

Weill Cornell Medicine Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464 Fax: (212) 746-8192